In a press release issued today ISCT has described the launch of its Cell Therapy Industry Partnership which will see many companies join with ISCT in a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development. According to Prof John Rasko, Regional Vice President of ISCT, "ISCT-Australia has been critical in contributing to the success of this important launch. We hope to continue our cooperation with the cell therapy industry in promoting all aspects of commercialisation and industry dialogue." The press release can be down loaded here - ISCT-Roche-Genzyme Partnership Press Release 13.08.10.pdf.